The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2011Tau Oligomers as a Potential Target for Treatment of Parkinson's Disease
Objective/Rationale:
Tau pathology is a prominent feature of synucleinopathies, such as Parkinson disease (PD) and dementia with Lewy Bodies (DLB). An emerging view in neurodegeneration is that... -
Resource: Utilizing DATATOP Biospecimens, 2011C-type Natriuretic Peptide (CNP): A Putative Biomarker of Neuronal Damage in Parkinson's Disease
Objective/Rationale:
CNP is a peptide produced by brain tissues where it acts to promote growth of nerve cells and their connections. Recent research in healthy humans has identified high... -
Rapid Response Innovation Awards, 2010Generation of a Novel Recombinant Protein Activator of GPR88
Objective/Rationale:
Dopamine replacement therapy activates neurons in a particular region of the brain, the striatum, leading to an improvement in disease symptoms. This action occurs through a... -
Rapid Response Innovation Awards, 2010Circulating microRNAs as Biomarkers for Early Detection of Parkinson's Disease
Objective/Rationale:
MicroRNAs (miRNAs) are small, conserved RNAs that interact with target sequences on messenger RNAs. MiRNAs have been proven to regulate the expression of many genes and play... -
MJFF Research Grant, 2010Generating and Characterizing LRRK2 Antibodies
Objective/Rationale:
LRRK2 is a gene implicated in the development of some familial Parkinson’s disease cases. Because of LRRK2’s significant potential as a drug target, MJFF is making considerable... -
MJFF Research Grant, 2010Comparison and Actions of MANF and GDNF in Rodent Models of Parkinson's Disease
Objective/Rationale:
Parkinson's disease (PD) is caused by the degeneration of certain dopaminergic neurons in the brain. Neurotrophic factors like GDNF protect dopaminergic neurons from degenerating...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.